Oct 22, 2026 09:07AM
Nov 5, 2025 01:56AM
Nov 4, 2025 08:06PM
Nov 3, 2025 09:24AM
Sep 16, 2025 09:32AM
Aug 22, 2025 07:04AM
Aug 12, 2025 06:41AM Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $30 at H.C. Wainwright
Aug 11, 2025 07:00AM
Jul 22, 2025 05:52PM
Jul 20, 2025 10:50AM
Jun 28, 2025 10:00AM
Jun 23, 2025 12:47PM
Jun 18, 2025 12:21PM
Jun 15, 2025 10:00AM INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVN
Jun 10, 2025 09:00AM
Jun 6, 2025 12:00PM
Jun 2, 2025 01:24PM
May 29, 2025 10:59AM
May 29, 2025 07:29AM
May 28, 2025 09:00AM
May 22, 2025 09:00AM INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVN
May 18, 2025 10:00AM
May 14, 2025 06:43PM
May 13, 2025 09:43AM
May 12, 2025 04:05PM
Apr 10, 2025 05:32AM
Mar 3, 2025 07:30AM
Jan 13, 2025 12:50PM RBC Capital Explores Biotech Implications Following Cavazzoni's Departure from the FDA
Jan 31, 2023 06:45AM
Oct 4, 2022 07:35AM
Oct 4, 2022 07:30AM
Oct 3, 2022 01:01PM
Oct 3, 2022 01:01PM
Aug 5, 2022 07:00AM
Jun 13, 2022 07:30AM Biohaven Presents New Migraine Data at 64th Annual Scientific Meeting of the American Headache Society, including First of Its Kind Study for Nurtec® ODT (rimegepant), and Complete Phase 3 Data for Z
Jun 9, 2022 07:30AM
May 23, 2022 07:31AM
May 23, 2022 07:30AM
May 28, 2021 09:25AM
May 27, 2021 05:45PM
Mar 1, 2021 07:30AM
Dec 16, 2020 07:31AM Biohaven Pharma's (BHVN) Rimegepant For Preventive Treatment Of Migraine Published In The Lancet
Dec 16, 2020 07:30AM
Dec 1, 2020 03:05AM
Nov 16, 2020 07:34AM
Nov 16, 2020 07:30AM
Nov 9, 2020 08:00AM
Oct 14, 2020 07:32AM
Oct 14, 2020 07:30AM U.S. FDA Accepts Biohaven's Supplemental New Drug Application (sNDA) Of NURTEC™ ODT For The Preventive Treatment Of Migraine
Feb 25, 2020 04:45PM

15,963 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All